Age-related macular degeneration (AMD) is a leading cause of vision loss in the U.S., affecting 11 million people, particularly older adults. The more severe form, neovascular age-related macular degeneration (nAMD), is characterized ...
Jul 9, 2024
0
18
Much like the Cold War space race, the world's pharmaceutical giants are currently scrambling to produce the best weight-loss drug. They all want to be the first to explore the nooks and crannies of the body in order to be ...
Jul 9, 2024
0
19
Published today in Cancer Cell, results of a study directed by Joaquin Mateo, Head of the Vall d'Hebron Institute of Oncology's (VHIO) Prostate Cancer Translational Research Group, show that DNA/RNA material contained in ...
Jul 8, 2024
0
24
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Jul 6, 2024
0
139
Promotional events sponsored by the pharmaceutical industry that target health professionals responsible for prescribing medications, such as physicians and nurse practitioners, are a key component of promotional campaigns ...
Jul 5, 2024
0
31
Cancer's resistance to chemotherapy could be reversed by targeting lactate—the product that builds up as cancer cells convert nutrients to energy, according to new research published in Nature.
Jul 4, 2024
0
31
Stem cells are like the emergency tool kit of the human body. They have the unique ability to form into other types of specialized cells—from immune cells to brain cells. They can divide and regenerate indefinitely to repair ...
Jul 4, 2024
0
54
A team at the Institute of Biochemistry at Kiel University has found a way to inhibit the function of the tumor-causing protein MYC. This can be used to develop new drugs.
Jul 4, 2024
0
42
A study led by investigators from Mass Eye and Ear found that patients prescribed semaglutide (as Ozempic or Wegovy) for diabetes or weight loss had a higher risk of having a potentially blinding eye condition called NAION ...
Jul 3, 2024
0
54
The main neuropathological feature of Parkinson's disease is the loss of dopaminergic neurons in the substantia nigra pars compacta. Specifically, dopaminergic neurons in the ventral tier of the substantia nigra pars compacta, ...
